City
Epaper

Ind-Ra assigns JSW Shipping & Logistics A-plus with stable outlook

By ANI | Updated: June 12, 2021 20:08 IST

India Ratings and Research (Ind-Ra) has assigned JSW Shipping and Logistics Pvt Ltd (JSLPL) a long-term issuer rating of A-plus with stable outlook.

Open in App

India Ratings and Research (Ind-Ra) has assigned JSW Shipping and Logistics Pvt Ltd (JSLPL) a long-term issuer rating of A-plus with stable outlook.

JSLPL's two-member board wholly comprises representatives from the JSW Group. Also, JSLPL's senior management team has been drawn from JSW Group companies.

Ind-Ra expects the JSW Group to monitor JSLPL's operations and financial position closely (including the treasury functions).

JSLPL started operations in January and FY22 will be the first full year of operations for the firm. The total project cost (the purchase price for 14 mini bulk carriers) is Rs 1,024 crore.

A total of five mini bulk carriers are operational as of now and the rest will be operational by 3Q FY22. The company has availed a disbursement of Rs 334 crore against seven mini bulk carriers.

According to the provisional financials for FY21, JSLPL achieved a revenue of Rs 14.5 crore with an operating margin of 60 per cent.

Overall, Ind-Ra views JSLPL to be operationally integral to the JSW Group, given the critical nature of services provided to JSWL, the flagship company in the group.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Jsw shipping and logistics pvt ltdIndia Ratings And Research
Open in App

Related Stories

BusinessEducation sector outlook improving driven by industry-oriented learning, digitalisation: India Ratings

BusinessFTA with Australia to create a level-playing field for garment textile exporters: India Ratings

InternationalIndia Ratings revise its FY23 GDP growth forecast downwards to 7-7.2%

InternationalRussia-Ukraine conflict: India's CAD to widen on rising commodity costs

InternationalBooster dose: India's pharma sector to grow at 6-8% YoY in FY23

Business Realted Stories

BusinessSolid monetary frameworks helped emerging markets navigate recent crises: Gita Gopinath

BusinessPiyush Goyal lashes out at Big Pharma for evergreening patents

BusinessSEBI joins DigiLocker to reduce unclaimed assets, protect nominees’ interests

BusinessOver 170 million lifted above poverty line in India, Modi government and Congress claim credit

BusinessIndia, as fastest growing economy, is ideal investment destination: RBI Governor